Algirdas Griskevicius
Overview
Explore the profile of Algirdas Griskevicius including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kohlenberg A, Svartstrom O, Apfalter P, Hartl R, Bogaerts P, Huang T, et al.
Euro Surveill
. 2024 Nov;
29(47).
PMID: 39574387
Analysis of 594 isolates of sequence type (ST)131 and its single locus variants carrying carbapenemase genes from 17 European Union/European Economic Area countries revealed acquisition of 18 carbapenemase variants, mainly...
2.
Greicius P, Linkevicius M, Razmuk J, Sinotova J, Alm E, Svartstrom O, et al.
Euro Surveill
. 2024 Apr;
29(16).
PMID: 38639094
In 2023, an increase of OXA-48-producing was noticed by the Lithuanian National Public Health Surveillance Laboratory. Whole genome sequencing (WGS) of 106 OXA-48-producing isolates revealed three distinct clusters of carbapenemase-producing...
3.
Berbers G, van Gageldonk P, van de Kassteele J, Wiedermann U, Desombere I, Dalby T, et al.
Nat Commun
. 2021 May;
12(1):2871.
PMID: 34001895
Reported incidence of pertussis in the European Union (EU) and the European Economic Area (EEA) varies and may not reflect the real situation, while vaccine-induced protection against diphtheria and tetanus...
4.
Rabalski L, Szewczyk B, Zagminas K, Griskevicius A, Lepek K
Microbiol Resour Announc
. 2021 Jan;
10(1).
PMID: 33414352
Here, we report the coding-complete genome sequences of six influenza A(H1N1) strains that were detected in Vilnius, Lithuania, among patients exhibiting influenza-like symptoms during the 2009-2010 epidemic season, within national...
5.
Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, et al.
Infect Genet Evol
. 2016 Jun;
46:169-179.
PMID: 27262355
Human immunodeficiency virus type 1 (HIV-1) was discovered in the early 1980s when the virus had already established a pandemic. For at least three decades the epidemic in the Western...
6.
Hofstra L, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al.
Clin Infect Dis
. 2015 Dec;
62(5):655-663.
PMID: 26620652
Background: Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug resistance testing to guide the choice of initial regimen....
7.
Angelis K, Albert J, Mamais I, Magiorkinis G, Hatzakis A, Hamouda O, et al.
J Infect Dis
. 2014 Dec;
211(11):1735-44.
PMID: 25512631
Background: Human immunodeficiency virus type 1 (HIV-1) subtype CRF01_AE originated in Africa and then passed to Thailand, where it established a major epidemic. Despite the global presence of CRF01_AE, little...
8.
Frentz D, van de Vijver D, Abecasis A, Albert J, Hamouda O, Jorgensen L, et al.
BMC Infect Dis
. 2014 Jul;
14:407.
PMID: 25047543
Background: One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance...
9.
Frentz D, Vijver D, Abecasis A, Albert J, Hamouda O, Jorgensen L, et al.
PLoS One
. 2014 Apr;
9(4):e94495.
PMID: 24721998
Background: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations...
10.
Frentz D, Wensing A, Albert J, Paraskevis D, Abecasis A, Hamouda O, et al.
Retrovirology
. 2013 Apr;
10:36.
PMID: 23551870
Background: International travel plays a role in the spread of HIV-1 across Europe. It is, however, not known whether international travel is more important for spread of the epidemic as...